Sales and Marketing

Showing 15 posts of 11527 posts found.

AstraZeneca begins lung cancer trial

May 9, 2014 Research and Development, Sales and Marketing AstraZeneca, Cancer, MEDI4736, NSCLC, lung cancer

AstraZeneca, currently at the centre of a £63 billion bid from US giant Pfizer, has begun a late-stage trial of …

Wellcome Trust slams Pfizer/AstraZeneca bid

May 9, 2014 Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover

The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …

ABPI appoints manager 
from Pfizer


May 9, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pfizer, christine rowland

The ABPI has appointed Christine Rowland to the newly-created position of value and access manager for its commercial department.  Rowland …

NICE recommends Xtandi

May 9, 2014 Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate

NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …

EU looks at eye drug allegations

May 8, 2014 Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel

European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …

3D printed hearts ‘on the horizon’

May 8, 2014 Medical Communications, Sales and Marketing 3D, heart, louisville, printing, williams

The ‘inherent design flaws’ of the human heart could become a thing of the past as new 3D printing technology …

Cobra Biologics appoints CSO


May 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, cobra biologics, smith

Contract manufacturing organisation Cobra Biologics has hired Dr Daniel Smith as its chief scientific officer. Smith has spent the last …

RPS: ‘Give pharma incentives’

May 8, 2014 Research and Development, Sales and Marketing NHS, RPS, rare diseases, royal pharmaceutical society

Incentives are urgently required to speed up the development of personalised medicines, according to a new report from the Royal …

ICON appoints non-executive director

May 7, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, brady

Contract research organisation (CRO) ICON has appointed Dr Hugh Brady as a non-executive director.  Brady previously served as president at …

Global cancer drug spend slows

May 7, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, IMS, spending

Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …

Bayer concludes $14bn Merck consumer care takeover

May 7, 2014 Sales and Marketing Bayer, Merck, OTC, consumer care, merger

 Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …

US cancer docs warn of rising drug prices

May 7, 2014 Research and Development, Sales and Marketing ASCO, Cancer, NICE, Obama, US, United States, republicans

American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …

Triducive recruits senior account manager

May 7, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Triducive, hannagan

Comms consultancy firm Triducive has expanded with the appointment of a new senior account manager in Lucy Hannagan. Hannagan joins …

Pfizer will ‘suck AZ’s lifeblood’

May 7, 2014 Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, bbd, cable, merger

A former boss of AstraZeneca has warned that he fears Pfizer “will act like a praying mantis and suck the …

Court stops Ranbaxy takeover

May 6, 2014 Manufacturing and Production, Sales and Marketing Ranbaxy, Sun Pharma, fad, manufacturing

An Indian court has stopped the sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries after concerns were raised over insider …
The Gateway to Local Adoption Series

Latest content